Comparison of periprosthetic tissues in knee and hip joints: Differential expression of CCL3 and DC-STAMP in total knee and hip arthroplasty and similar cytokine profiles in primary knee and hip osteoarthritis

Osteoarthritis and Cartilage

Volumn 22, Issue 11, 2014, Pages 1851-1860

  Tomankova, T ^a   Kriegova, E ^a   Fillerova, R ^a   Luzna, P ^a   Ehrmann, J ^a   Gallo, J ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

Aseptic loosening; Cytokines; Gene expression profile; Osteoarthritis; Total hip arthroplasty; Total knee arthroplasty

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; CYTOKINE; DENDRITIC CELL SPECIFIC TRANSMEMBRANE PROTEIN; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MEMBRANE PROTEIN; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; CCL3 PROTEIN, HUMAN; DCSTAMP PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; GENE EXPRESSION; HARRIS HIP SCORE; HIP OSTEOARTHRITIS; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; KNEE OSTEOARTHRITIS; KNEE SOCIETY SCORE; MALE; OSTEOARTHRITIS; PROSTHESIS LOOSENING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; TREATMENT FAILURE; TREATMENT OUTCOME; VERY ELDERLY; ARTHROPLASTY; BIOSYNTHESIS; COMPARATIVE STUDY; GENE EXPRESSION REGULATION; GENETICS; HIP; HIP ARTHROPLASTY; KNEE; KNEE ARTHROPLASTY; METABOLISM; MIDDLE AGED; OSTEOARTHRITIS, HIP; OSTEOARTHRITIS, KNEE; PROCEDURES; RETROSPECTIVE STUDY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; CHEMOKINE CCL3; CYTOKINES; FEMALE; GENE EXPRESSION REGULATION; HIP JOINT; HUMANS; IMMUNOHISTOCHEMISTRY; KNEE JOINT; MALE; MEMBRANE PROTEINS; MIDDLE AGED; OSTEOARTHRITIS, HIP; OSTEOARTHRITIS, KNEE; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84908226416     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2014.08.004     Document Type: Article

References (59)

1. Sundfeldt M., Carlsson L.V., Johansson C.B., Thomsen P., Gretzer C. Aseptic loosening, not only a question of wear: a review of different theories. Acta Orthop 2006, 77:177-197.
2. Gallo J., Vaculova J., Goodman S.B., Konttinen Y.T., Thyssen J.P. Contributions of human tissue analysis to understanding the mechanisms of loosening and osteolysis in total hip replacement. Acta Biomater 2014, 10:2354-2366.
3. Gallo J., Goodman S.B., Konttinen Y.T., Raska M. Particle disease: biologic mechanisms of periprosthetic osteolysis in total hip arthroplasty. Innate Immun 2013, 19:213-224.
4. Gallo J., Goodman S.B., Konttinen Y.T., Wimmer M.A., Holinka M. Osteolysis around total knee arthroplasty: a review of pathogenetic mechanisms. Acta Biomater 2013, 9:8046-8058.
5. Hallab N.J., Jacobs J.J. Biologic effects of implant debris. Bull NYU Hosp Jt Dis 2009, 67:182-188.
6. Greenfield E.M., Beidelschies M.A., Tatro J.M., Goldberg V.M., Hise A.G. Bacterial pathogen-associated molecular patterns stimulate biological activity of orthopaedic wear particles by activating cognate Toll-like receptors. JBiol Chem 2010, 285:32378-32384.
7. Miyanishi K., Trindade M.C., Ma T., Goodman S.B., Schurman D.J., Smith R.L. Periprosthetic osteolysis: induction of vascular endothelial growth factor from human monocyte/macrophages by orthopaedic biomaterial particles. JBone Miner Res 2003, 18:1573-1583.
8. Anderson J.M., Rodriguez A., Chang D.T. Foreign body reaction to biomaterials. Semin Immunol 2008, 20:86-100.
9. Koreny T., Tunyogi-Csapo M., Gal I., Vermes C., Jacobs J.J., Glant T.T. The role of fibroblasts and fibroblast-derived factors in periprosthetic osteolysis. Arthritis Rheum 2006, 54:3221-3232.
10. Purdue P.E., Koulouvaris P., Nestor B.J., Sculco T.P. The central role of wear debris in periprosthetic osteolysis. HSS J 2006, 2:102-113.
11. Mandelin J., Li T.F., Liljestrom M., Kroon M.E., Hanemaaijer R., Santavirta S., et al. Imbalance of RANKL/RANK/OPG system in interface tissue in loosening of total hip replacement. JBone Joint Surg Br 2003, 85:1196-1201.
12. Wang C.T., Lin Y.T., Chiang B.L., Lee S.S., Hou S.M. Over-expression of receptor activator of nuclear factor-kappaB ligand (RANKL), inflammatory cytokines, and chemokines in periprosthetic osteolysis of loosened total hip arthroplasty. Biomaterials 2010, 31:77-82.
13. Gibon E., Yao Z., Rao A.J., Zwingenberger S., Batke B., Valladares R., et al. Effect of a CCR1 receptor antagonist on systemic trafficking of MSCs and polyethylene particle-associated bone loss. Biomaterials 2012, 33:3632-3638.
14. Takei I., Takagi M., Santavirta S., Ida H., Ishii M., Ogino T., et al. Messenger ribonucleic acid expression of 16 matrix metalloproteinases in bone-implant interface tissues of loose artificial hip joints. JBiomed Mater Res 2000, 52:613-620.
15. Pioletti D.P., Leoni L., Genini D., Takei H., Du P., Corbeil J. Gene expression analysis of osteoblastic cells contacted by orthopedic implant particles. JBiomed Mater Res 2002, 61:408-420.
16. Garrigues G.E., Cho D.R., Rubash H.E., Goldring S.R., Herndon J.H., Shanbhag A.S. Gene expression clustering using self-organizing maps: analysis of the macrophage response to particulate biomaterials. Biomaterials 2005, 26:2933-2945.
17. Koulouvaris P., Ly K., Ivashkiv L.B., Bostrom M.P., Nestor B.J., Sculco T.P., et al. Expression profiling reveals alternative macrophage activation and impaired osteogenesis in periprosthetic osteolysis. JOrthop Res 2008, 26:106-116.
18. Rakshit D.S., Ly K., Sengupta T.K., Nestor B.J., Sculco T.P., Ivashkiv L.B., et al. Wear debris inhibition of anti-osteoclastogenic signaling by interleukin-6 and interferon-gamma. Mechanistic insights and implications for periprosthetic osteolysis. JBone Joint Surg Am 2006, 88:788-799.
19. Saleh K.J., Holtzman J., Gafni A., Saleh L., Davis A., Resig S., et al. Reliability and intraoperative validity of preoperative assessment of standardized plain radiographs in predicting bone loss at revision hip surgery. JBone Joint Surg Am 2001, 83-A:1040-1046.
20. Engh G.A., Ammeen D.J. Bone loss with revision total knee arthroplasty: defect classification and alternatives for reconstruction. Instr Course Lect 1999, 48:167-175.
21. Gallo J., Kolar M., Dendis M., Loveckova Y., Sauer P., Zapletalova J., et al. Culture and PCR analysis of joint fluid in the diagnosis of prosthetic joint infection. New Microbiol 2008, 31:97-104.
22. Mandelin J., Liljestrom M., Li T.F., Ainola M., Hukkanen M., Salo J., et al. Pseudosynovial fluid from loosened total hip prosthesis induces osteoclast formation. JBiomed Mater Res B Appl Biomater 2005, 74:582-588.
23. Konttinen Y.T., Xu J.W., Waris E., Li T.F., Gomez-Barrena E., Nordsletten L., et al. Interleukin-6 in aseptic loosening of total hip replacement prostheses. Clin Exp Rheumatol 2002, 20:485-490.
24. Pinol I., Torres A., Gil G., Prats E., Puig-Verdier L., Hinarejos P. Polyethylene particles in joint fluid and osteolysis in revision total knee arthroplasty. Knee 2014, 21:402-405.
25. Nygaard M., Elling F., Bastholm L., Soballe K., Borgwardt A. No difference in early cellular response of the pseudo-synovial membrane after total hip arthroplasty: comparison of 3 combinations of bearing materials. Acta Orthop 2006, 77:402-412.
26. Onodera S., Suzuki K., Matsuno T., Kaneda K., Takagi M., Nishihira J. Macrophage migration inhibitory factor induces phagocytosis of foreign particles by macrophages in autocrine and paracrine fashion. Immunology 1997, 92:131-137.
27. Hukkanen M., Corbett S.A., Platts L.A., Konttinen Y.T., Santavirta S., Hughes S.P., et al. Nitric oxide in the local host reaction to total hip replacement. Clin Orthop Relat Res 1998, 53-65.
28. Kriegova E., Arakelyan A., Fillerova R., Zatloukal J., Mrazek F., Navratilova Z., et al. PSMB2 and RPL32 are suitable denominators to normalize gene expression profiles in bronchoalveolar cells. BMC Mol Biol 2008, 9:69.
29. Takacova S., Slany R., Bartkova J., Stranecky V., Dolezel P., Luzna P., et al. DNA damage response and inflammatory signaling limit the MLL-ENL-induced leukemogenesis invivo. Cancer Cell 2012, 21:517-531.
30. Lin T.H., Tamaki Y., Pajarinen J., Waters H.A., Woo D.K., Yao Z., et al. Chronic inflammation in biomaterial-induced periprosthetic osteolysis: NF-kappaB as a therapeutic target. Acta Biomater 2014, 10:1-10.
31. Abu-Amer Y. NF-kappaB signaling and bone resorption. Osteoporos Int 2013, 24:2377-2386.
32. Pearle A.D., Crow M.K., Rakshit D.S., Wohlgemuth J., Nestor B.J. Distinct inflammatory gene pathways induced by particles. Clin Orthop Relat Res 2007, 458:194-201.
33. Lassus J., Waris V., Xu J.W., Li T.F., Hao J., Nietosvaara Y., et al. Increased interleukin-8 (IL-8) expression is related to aseptic loosening of total hip replacement. Arch Orthop Trauma Surg 2000, 120:328-332.
34. Shanbhag A.S., Kaufman A.M., Hayata K., Rubash H.E. Assessing osteolysis with use of high-throughput protein chips. JBone Joint Surg Am 2007, 89:1081-1089.
35. Di Rosa M., Malaguarnera G., De Gregorio C., D'Amico F., Mazzarino M.C., Malaguarnera L. Modulation of chitotriosidase during macrophage differentiation. Cell Biochem Biophys 2013, 66:239-247.
36. Zhang Z., Shively J.E. Acceleration of bone repair in NOD/SCID mice by human monoosteophils, novel LL-37-activated monocytes. PLoS One 2013, 8:e67649.
37. Bondeson J., Wainwright S.D., Lauder S., Amos N., Hughes C.E. The role of synovial macrophages and macrophage-produced cytokines in driving aggrecanases, matrix metalloproteinases, and other destructive and inflammatory responses in osteoarthritis. Arthritis Res Ther 2006, 8:R187.
38. Clarke S.A., Brooks R.A., Hobby J.L., Wimhurst J.A., Myer B.J., Rushton N. Correlation of synovial fluid cytokine levels with histological and clinical parameters of primary and revision total hip and total knee replacements. Acta Orthop Scand 2001, 72:491-498.
39. Darowish M., Rahman R., Li P., Bukata S.V., Gelinas J., Huang W., et al. Reduction of particle-induced osteolysis by interleukin-6 involves anti-inflammatory effect and inhibition of early osteoclast precursor differentiation. Bone 2009, 45:661-668.
40. Yan C., Cao J., Wu M., Zhang W., Jiang T., Yoshimura A., et al. Suppressor of cytokine signaling 3 inhibits LPS-induced IL-6 expression in osteoblasts by suppressing CCAAT/enhancer-binding protein {beta} activity. JBiol Chem 2010, 285:37227-37239.
41. Gao A., Van Dyke T.E. Role of suppressors of cytokine signaling 3 in bone inflammatory responses. Front Immunol 2014, 4:506.
42. Gallo J., Zdarilova A., Rajnochova Svobodova A., Ulrichova J., Radova L., Smizansky M. Synovial fluid from aseptically failed total hip or knee arthroplasty is not toxic to osteoblasts. Acta Chir Orthop Traumatol Cech 2010, 77:416-424.
43. Grimaud E., Soubigou L., Couillaud S., Coipeau P., Moreau A., Passuti N., et al. Receptor activator of nuclear factor kappaB ligand (RANKL)/osteoprotegerin (OPG) ratio is increased in severe osteolysis. Am J Pathol 2003, 163:2021-2031.
44. Lind M., Trindade M.C., Schurman D.J., Goodman S.B., Smith R.L. Monocyte migration inhibitory factor synthesis and gene expression in particle-activated macrophages. Cytokine 2000, 12:909-913.
45. Yaszay B., Trindade M.C., Lind M., Goodman S.B., Smith R.L. Fibroblast expression of C-C chemokines in response to orthopaedic biomaterial particle challenge invitro. JOrthop Res 2001, 19:970-976.
46. Wagner C., Heck D., Lautenschlager K., Iking-Konert C., Heppert V., Wentzensen A., et al. Tlymphocytes in implant-associated posttraumatic osteomyelitis: identification of cytotoxic T effector cells at the site of infection. Shock 2006, 25:241-246.
47. Nakashima Y., Sun D.H., Trindade M.C., Chun L.E., Song Y., Goodman S.B., et al. Induction of macrophage C-C chemokine expression by titanium alloy and bone cement particles. JBone Joint Surg Br 1999, 81:155-162.
48. Dapunt U., Maurer S., Giese T., Gaida M.M., Hansch G.M. The macrophage inflammatory proteins MIP1alpha (CCL3) and MIP2alpha (CXCL2) in implant-associated osteomyelitis: linking inflammation to bone degradation. Mediators Inflamm 2014, 2014:728619.
49. Khan U.A., Hashimi S.M., Khan S., Quan J., Bakr M.M., Forwood M.R., et al. Differential expression of chemokines, chemokine receptors and proteinases by foreign body giant cells (FBGCs) and osteoclasts. JCell Biochem 2014, 115:1290-1298.
50. Zhang C., Dou C., Xu J., Dong S. DC-STAMP, the key fusion-mediating molecule in osteoclastogenesis. JCell Physiol 2014, 229:1330-1335.
51. Sanecka A., Ansems M., Prosser A.C., Danielski K., Warner K., den Brok M.H., et al. DC-STAMP knock-down deregulates cytokine production and T-cell stimulatory capacity of LPS-matured dendritic cells. BMC Immunol 2011, 12:57.
52. Yagi M., Ninomiya K., Fujita N., Suzuki T., Iwasaki R., Morita K., et al. Induction of DC-STAMP by alternative activation and downstream signaling mechanisms. JBone Miner Res 2007, 22:992-1001.
53. Takayanagi H. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol 2007, 7:292-304.
54. Shanbhag A.S., Bailey H.O., Hwang D.S., Cha C.W., Eror N.G., Rubash H.E. Quantitative analysis of ultrahigh molecular weight polyethylene (UHMWPE) wear debris associated with total knee replacements. JBiomed Mater Res 2000, 53:100-110.
55. Fahlgren A., Bostrom M.P., Yang X., Johansson L., Edlund U., Agholme F., et al. Fluid pressure and flow as a cause of bone resorption. Acta Orthop 2010, 81:508-516.
56. Henrotin Y., Pesesse L., Lambert C. Targeting the synovial angiogenesis as a novel treatment approach to osteoarthritis. Ther Adv Musculoskelet Dis 2014, 6:20-34.
57. Hou C., Zhang Y., Yu S., Li Z., Zhai Q., Li Z., et al. Presence of interleukin-17C in the tissue around aseptic loosened implants. Int Orthop 2013, 37:953-959.
58. Hercus B., Saeed S., Revell P.A. Expression profile of T cell associated molecules in the interfacial tissue of aseptically loosened prosthetic joints. JMater Sci Mater Med 2002, 13:1153-1156.
59. Sato K., Suematsu A., Okamoto K., Yamaguchi A., Morishita Y., Kadono Y., et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. JExp Med 2006, 203:2673-2682.